Stress urinary incontinence (SUI), a frequently underdiagnosed condition that mainly affects women, lacks effective and long-term treatment options.MUVON Therapeutics has developed a tissue-engineered advanced therapy medicinal product for the treatment of SUI, based on autologous cells, which is being tested in a phase II clin. study - a challenging development effort.